VSI Spine Surgeons Reach Milestone: 100th Augmented Reality-Assisted Spinal Fusion Surgery 
Genomes.io Joins Tachyon 2.0: ConsenSys Ventures Blockchain-Focused Accelerator
BERLIN, April 1, 2019 /PRNewswire/ -- Genomes.io, the London-based startup using blockchain technology to give people ownership and control over their genomic...
New Direct-Sampling Ion Source Simplifies Sample Preparation in Routine Applications
PALM SPRINGS, Calif., April 1, 2019 /PRNewswire/ -- MSACL US 2019 -- Laboratories can deliver the rapid quantitation of time-critical...
DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage™ Remote Digital Diabetes Platform
NEW YORK and CAESAREA, Israel, April 1, 2019 /PRNewswire/ -- Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an...
New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories
PALM SPRINGS, Calif., April 1, 2019 /PRNewswire/ -- MSACL US 2019 – Thermo Fisher Scientific announces the expansion of its portfolio of...
Aave Announces a Recovery Program for “Crypto Addicted”
ZUG, Switzerland, April 1, 2019 /PRNewswire/ -- AAVE, a UK-based fintech startup, today revealed its rehabilitation program aimed at helping...
World’s frogs under assault by lone pathogenic killer, FIU scientist says
MIAMI, March, 29, 2019 /PRNewswire/ -- A single fungal disease has wiped out at least 90 species of amphibians and had...
WuXi NextCODE Launches New State-of-the-art Genetic Analysis Laboratory in U.S. with Illumina’s New TruSight 500™ Assay
CAMBRIDGE, Mass. and SHANGHAI, March 30, 2019 /PRNewswire/ -- WuXi NextCODE, a global genomic data and insights company, is expanding...
Genmed appoints Nicky Carless as national sales manager
April 2, 2019 – Genmed, a specialist provider of vendor neutral managed services to the NHS, today announces the appointment...
Gateshead Health extends use of BridgeHead’s HealthStore®
BridgeHead’s Independent Clinical Archive will now house all medical images across the TrustASHTEAD, UK – 2 April 2019 – As...
Jaguar Health Subsidiary Napo Pharmaceuticals Issues Further Regulatory Update Regarding Potential Follow-on Indication for Mytesi
SAN FRANSISCO, CA / ACCESSWIRE / April 2, 2019 / Napo Pharmaceuticals, Inc. (Napo), a human health company developing and...
Sun Life and Maxwell Health launch new digital benefits platform to enhance employee enrollment and ease employer administrative burdens
WELLESLEY, Mass., April 1, 2019 /PRNewswire/ -- Sun Life and Maxwell Health have launched a combined benefits technology solution, providing...
Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations
PLANEGG/MUNICH GERMANY / ACCESSWIRE / April 1, 2019 / Dr. Sarah Fakih joined MorphoSys AG (FSE: MOR; Prime Standard Segment,...
ReShape Lifesciences Announces Fourth Quarter and Full Year 2018 Financial Results
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive...
Kadmon Announces Appointment of Arthur Kirsch to Board of Directors
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Arthur Kirsch...
NHS doctors train using virtual reality to improve care for people with diabetes
The NHS England diabetes team has partnered with Oxford Medical Simulation to train doctors using virtual reality. Doctors can now...
Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder
PH94B has potential to be the First FDA-Approved PRN Treatment for Social Anxiety Disorder New Findings Presented at the 2019...
Experion Completes First Shipment to the Province of Saskatchewan
CALGARY, AB / ACCESSWIRE / April 1, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis
AUSTIN, TX / ACCESSWIRE / April 1, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced...
ReShape Lifesciences Implants First Patient in ENDURE II Trial to Support CE Marking of ReShape Vest
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Parallax Health Sciences Reports 2018 Operating and Financial Results Records Net Income of $16.3 Million
Initiates $6 Million Equity Financing Company Now Positioned for Growth through Execution on Multi-faceted Strategy SANTA MONICA, CALIF / ACCESSWIRE...